Our services span the entire lifecycle of product development and commercialisation, and can be adapted to suit small local trials or large global .. Read more programs. We have extensive experience in a broad range of therapeutic areas. Managing studies in all major geographies, we have established solid working relationships with the world’s leading investigators. ICON has recently led the development of 17 vaccines resulting in FDA/EMA approvals. We are currently working on a number of COVID-19 vaccine trials. ICON provides analysis and key insights on these challenges, with practical advice and recommendations. ICON regularly contributes thought leadership to industry media publications and conferences, and has been recognised as one of the world’s leading Contract Research Organisations through a number of high-profile industry awards.
- Share your Experience
More Events From The Organizer
- Cardiovascular Event adjudicat..21 May 2021Online